Cyclosporine in the treatment of myasthenia gravis

Acta Neurologica Scandinavica

Volumn 111, Issue 4, 2005, Pages 247-252

  Lavrnic, Dragana ^a   Vujic, A ^a   Rakocevic Stojanovic, V ^a   Stevic, Z ^a   Basta, I ^a   Pavlovic, S ^a   Trikic, R ^a   Apostolski, S ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Cyclosporine; Immunosuppression; Myasthenia gravis

Indexed keywords

AZATHIOPRINE; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; DIARRHEA; DISABILITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; GINGIVA HYPERPLASIA; HEADACHE; HUMAN; HYPERTENSION; HYPERTRICHOSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; MYALGIA; MYASTHENIA GRAVIS; NAUSEA; NEPHROTOXICITY; PARESTHESIA; REMISSION; TASTE DISORDER; THYMECTOMY;

EID: 15044355239     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00378.x     Document Type: Article

References (25)

1. ENGEL AG. Myasthenia gravis and myasthenic syndromes. Ann Neurol 1984;16:47-54.
2. SIMPSON JA. Myasthenia gravis. A new hypothesis. Scot Med J 1960;5:419-36.
3. JOHNS TR. Long-term corticosteroid treatment of myasthenia gravis. Ann N Y Acad Sci 1987;505:568-83.
4. CORNELLIO F, ANTOZZI C, MANTEGAZZA R et al. Immunosuppressive treatments. Their efficacy on myasthenia gravis patients' outcome and on the natural course of the disease. Ann N Y Acad Sci 1993;681:594-602.
5. WILENSKY R, DWYER B, MAYER RF. Relapses in patients with myasthenia gravis treated with azathioprine. Ann N Y Acad Sci 1993;681:591-3.
6. KAHAN BD. Drug therapy: cyclosporine. N Engl J Med 1989;321:172S-37.
7. GOULON M, ELKHARRAT D, GAJDOS P. Treatment of severe myasthenia gravis with cyclosporine. A 12-month open trial. La Presse Med 1989;18:341-6.
8. TINDALL RSA, PHILLIPS JT, ROLLINS JA, WELLS L, HALL K. A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann N Y Acad Sci 1993;681:539-51.
9. FAULDS D, GOA KL, BENFIELD P. Cyclosporine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993;45:953-1040.
10. BONIFATI DM, ANGELINI C. Long-term cyclosporine treatment in a group of severe myasthenia gravis patients. J Neurol 1997;244:542-7.
11. CIAFALONI E, NIKHAR NK, MASSEY JM, SANDERS DB. Retrospective analysis of the use of cyclosporine in myasthenia gravis. Neurology 2000;55:448-50.
12. LIU J. FK 506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol Today 1993;14:290.
13. SCHREIBER SL, CRABTREE GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-42.
14. KAHAN BD, GREVEL J. Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy. Transplantation 1988;46:631-44.
15. THE CANADIAN MULTICENTRE TRANSPLANT STUDY GROUP. A randomized clinical trial of cyclosporine in cadaveric renal transplantation: analysis at three years. N Engl J Med 1986;314:1219-25.
16. OYER PE, STINSON EB, JAMIESON SW. Cyclosporine in cardiac transplantation: a 21/2 year follow-up. Transplant Proc 1983;15(Suppl. 1):2546-52.
17. CASPERS-VELU LE, DECAUX G, LIBERT J. Cyclosporine in Behcet's disease resistant to conventional therapy. Ann Opthalmol 1989;21:111-6.
18. DOYLE DV, HUSKISSON EC, GREENWOOD A, DACRE AJM. Psoriatic arthritis: a placebo controlled study of treatment with cyclosporin A and azathioprine. Br J Rheumatol 1987;28(Suppl. 1):53-6.
19. HYAMS JS, BALLOW M, LEICHTNER AM. Cyclosporine treatment of autoimmune chronic active hepatitis. Gastroenterology 1987;93:890-3.
20. GUNN HC, HIESTANA PC, HANGLOW AC. Cyclosporine treatment in experimental autoimmune myasthenia gravis. Monogr Allergy 1988;25:96-107.
21. TINDALL RSA, PHILLIPS JT, ROLLINS JA, GREENLEE RG, WELLS L, BELENDIUK G. Cyclosporine in the treatment of myasthenia gravis. Monogr Allergy 1988;25:135-47.
22. NYBERG-HANSEN R, GJERSTAD L. Myasthenia gravis treated with cyclosporine. Acta Neurol Scand 1988;77:307-13.
23. GOULON M, ELKHARRAT D, LOKIEC F, GAJDOS P. Results of a one-year open trial of cyclosporine in ten patients with severe myasthenia gravis. Transplant Proc 1988;20 (Suppl. 4):211-7.
24. BESINGER UA, TOYKA KV, HOMBERG M, HEININGER K, HOHLFELD R, FATEH-MOGHADAM A. Myasthenia gravis: long term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 1983;33:1316-21.
25. OOSTERHUIS HJGH. Observation of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci 1981;377:678-89.